Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy

Gillian Hunter, Rachael A. Powis, Ross A. Jones, Ewout J.N. Groen, Hannah K. Shorrock, Fiona M. Lane, Yinan Zheng, Diane L. Sherman, Peter J. Brophy, Thomas H. Gillingwater

Research output: Contribution to journalArticle

75 Downloads (Pure)

Abstract

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity. Here, we investigated the role of glial cells in the peripheral nervous system by creating SMA mice selectively overexpressing SMN in myelinating Schwann cells (Smn-/-;SMN2tg/0;SMN1SC). Restoration of SMN protein levels restricted solely to Schwann cells reversed myelination defects, significantly improved neuromuscular function and ameliorated neuromuscular junction pathology in SMA mice. However, restoration of SMN in Schwann cells had no impact on motor neuron soma loss from the spinal cord or ongoing systemic and peripheral pathology. This study provides evidence for a defined, intrinsic contribution of glial cells to SMA disease pathogenesis and suggests that therapies designed to include Schwann cells in their target tissues may be beneficial in generating a full rescue of disease symptoms.
Original languageEnglish
Pages (from-to)2853-2861
Number of pages9
JournalHuman Molecular Genetics
Volume25
Issue number13
Early online date11 May 2016
DOIs
Publication statusPublished - 1 Jul 2016

Fingerprint

Spinal Muscular Atrophy
Schwann Cells
Neuroglia
Motor Neurons
Pathology
Neuromuscular Diseases
Neuromuscular Junction
Peripheral Nervous System
Carisoprodol
Muscular Diseases
Spinal Cord
Proteins

Keywords

  • SMA
  • Schwann cell
  • motor neurons
  • spinal muscular atrophy
  • neuromuscular junction
  • mice
  • pathology
  • spinal cord
  • myelination
  • neuromuscular function

Cite this

Hunter, G., Powis, R. A., Jones, R. A., Groen, E. J. N., Shorrock, H. K., Lane, F. M., ... Gillingwater, T. H. (2016). Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. Human Molecular Genetics, 25(13), 2853-2861. https://doi.org/10.1093/hmg/ddw141
Hunter, Gillian ; Powis, Rachael A. ; Jones, Ross A. ; Groen, Ewout J.N. ; Shorrock, Hannah K. ; Lane, Fiona M. ; Zheng, Yinan ; Sherman, Diane L. ; Brophy, Peter J. ; Gillingwater, Thomas H. / Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. In: Human Molecular Genetics. 2016 ; Vol. 25, No. 13. pp. 2853-2861.
@article{83bddd0bcc7f45ddbbdfe36d45ad8684,
title = "Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy",
abstract = "Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity. Here, we investigated the role of glial cells in the peripheral nervous system by creating SMA mice selectively overexpressing SMN in myelinating Schwann cells (Smn-/-;SMN2tg/0;SMN1SC). Restoration of SMN protein levels restricted solely to Schwann cells reversed myelination defects, significantly improved neuromuscular function and ameliorated neuromuscular junction pathology in SMA mice. However, restoration of SMN in Schwann cells had no impact on motor neuron soma loss from the spinal cord or ongoing systemic and peripheral pathology. This study provides evidence for a defined, intrinsic contribution of glial cells to SMA disease pathogenesis and suggests that therapies designed to include Schwann cells in their target tissues may be beneficial in generating a full rescue of disease symptoms.",
keywords = "SMA, Schwann cell, motor neurons, spinal muscular atrophy, neuromuscular junction, mice, pathology, spinal cord, myelination, neuromuscular function",
author = "Gillian Hunter and Powis, {Rachael A.} and Jones, {Ross A.} and Groen, {Ewout J.N.} and Shorrock, {Hannah K.} and Lane, {Fiona M.} and Yinan Zheng and Sherman, {Diane L.} and Brophy, {Peter J.} and Gillingwater, {Thomas H.}",
note = "{\circledC} The Author (2016). Published by Oxford University Press on behalf of the Human Molecular Genetics. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Wellcome Trust funded APC, compliant with funder policy.",
year = "2016",
month = "7",
day = "1",
doi = "10.1093/hmg/ddw141",
language = "English",
volume = "25",
pages = "2853--2861",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "13",

}

Hunter, G, Powis, RA, Jones, RA, Groen, EJN, Shorrock, HK, Lane, FM, Zheng, Y, Sherman, DL, Brophy, PJ & Gillingwater, TH 2016, 'Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy', Human Molecular Genetics, vol. 25, no. 13, pp. 2853-2861. https://doi.org/10.1093/hmg/ddw141

Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. / Hunter, Gillian; Powis, Rachael A.; Jones, Ross A.; Groen, Ewout J.N.; Shorrock, Hannah K.; Lane, Fiona M.; Zheng, Yinan; Sherman, Diane L.; Brophy, Peter J.; Gillingwater, Thomas H.

In: Human Molecular Genetics, Vol. 25, No. 13, 01.07.2016, p. 2853-2861.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy

AU - Hunter, Gillian

AU - Powis, Rachael A.

AU - Jones, Ross A.

AU - Groen, Ewout J.N.

AU - Shorrock, Hannah K.

AU - Lane, Fiona M.

AU - Zheng, Yinan

AU - Sherman, Diane L.

AU - Brophy, Peter J.

AU - Gillingwater, Thomas H.

N1 - © The Author (2016). Published by Oxford University Press on behalf of the Human Molecular Genetics. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Wellcome Trust funded APC, compliant with funder policy.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity. Here, we investigated the role of glial cells in the peripheral nervous system by creating SMA mice selectively overexpressing SMN in myelinating Schwann cells (Smn-/-;SMN2tg/0;SMN1SC). Restoration of SMN protein levels restricted solely to Schwann cells reversed myelination defects, significantly improved neuromuscular function and ameliorated neuromuscular junction pathology in SMA mice. However, restoration of SMN in Schwann cells had no impact on motor neuron soma loss from the spinal cord or ongoing systemic and peripheral pathology. This study provides evidence for a defined, intrinsic contribution of glial cells to SMA disease pathogenesis and suggests that therapies designed to include Schwann cells in their target tissues may be beneficial in generating a full rescue of disease symptoms.

AB - Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity. Here, we investigated the role of glial cells in the peripheral nervous system by creating SMA mice selectively overexpressing SMN in myelinating Schwann cells (Smn-/-;SMN2tg/0;SMN1SC). Restoration of SMN protein levels restricted solely to Schwann cells reversed myelination defects, significantly improved neuromuscular function and ameliorated neuromuscular junction pathology in SMA mice. However, restoration of SMN in Schwann cells had no impact on motor neuron soma loss from the spinal cord or ongoing systemic and peripheral pathology. This study provides evidence for a defined, intrinsic contribution of glial cells to SMA disease pathogenesis and suggests that therapies designed to include Schwann cells in their target tissues may be beneficial in generating a full rescue of disease symptoms.

KW - SMA

KW - Schwann cell

KW - motor neurons

KW - spinal muscular atrophy

KW - neuromuscular junction

KW - mice

KW - pathology

KW - spinal cord

KW - myelination

KW - neuromuscular function

U2 - 10.1093/hmg/ddw141

DO - 10.1093/hmg/ddw141

M3 - Article

VL - 25

SP - 2853

EP - 2861

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 13

ER -